X
GW confident epilepsy drug will get NHS funding despite NICE rejection
https://pharmaphorum.com/news/no-repeat-of/
GW Pharma
FDA advisers back GW’s Epidiolex for rare epilepsy
UK firm’s potential blockbuster on course for approval
GW prepares US for cannabis-based epilepsy drug
GW pushing for legal clearance in some states
GW files cannabis-based epilepsy drug in EU and US
After Sativex disappointment, Epidiolex could transform GW’s fortunes.
GW prepares for 2018 US launch of epilepsy drug
But Zynerba’s cannabis epilepsy drug fails in phase 2.
GW close to filing cannabis-based epilepsy drug
Epidiolex could become a blockbuster if approved in all uses.
Progress in neurology for Celgene and GW
GW goes to FDA with cannabinoid epilepsy drug.
1 2